OBJECTIVE: To determine whether percutaneous (intramuscular) neuromuscular electric stimulation (perc-NMES) is less painful than transcutaneous neuromuscular electric stimulation (trans-NMES) for treating shoulder subluxation in hemiplegia. DESIGN: Double-blind, crossover trial. SETTING:University-affiliated tertiary care hospital. PARTICIPANTS: A convenience sample of 10 hemiplegic subjects with at least 1 fingerbreadth of glenohumeral subluxation. INTERVENTIONS: All subjects received 3 randomly ordered pairs of perc-NMES and trans-NMES to the supraspinatus and posterior deltoid muscles of the subluxated shoulder. Both types of stimulation were optimized to provide full joint reduction with minimal discomfort. MAIN OUTCOME MEASURES: Pain was assessed after each stimulation with a 10-cm visual analog scale (VAS) and the McGill Pain Questionnaire, using the Pain Rating Index (PRI) scoring method. Subjects were asked which type of stimulation they would prefer for 6 weeks of treatment. Wilcoxon's signed-rank test was used to compare median differences in VAS and PRI between perc-NMES and trans-NMES. RESULTS:Median VAS scores for perc-NMES and trans-NMES were 1 and 5.7, respectively (p = .007). Median PRI scores for perc-NMES and trans-NMES were 7 and 19.5, respectively (p = .018). Nine of the 10 subjects preferred perc-NMES to trans-NMES for treatment. CONCLUSION: Data suggest that perc-NMES is less painful than trans-NMES in the treatment of shoulder subluxation in hemiplegia.
RCT Entities:
OBJECTIVE: To determine whether percutaneous (intramuscular) neuromuscular electric stimulation (perc-NMES) is less painful than transcutaneous neuromuscular electric stimulation (trans-NMES) for treating shoulder subluxation in hemiplegia. DESIGN: Double-blind, crossover trial. SETTING: University-affiliated tertiary care hospital. PARTICIPANTS: A convenience sample of 10 hemiplegic subjects with at least 1 fingerbreadth of glenohumeral subluxation. INTERVENTIONS: All subjects received 3 randomly ordered pairs of perc-NMES and trans-NMES to the supraspinatus and posterior deltoid muscles of the subluxated shoulder. Both types of stimulation were optimized to provide full joint reduction with minimal discomfort. MAIN OUTCOME MEASURES: Pain was assessed after each stimulation with a 10-cm visual analog scale (VAS) and the McGill Pain Questionnaire, using the Pain Rating Index (PRI) scoring method. Subjects were asked which type of stimulation they would prefer for 6 weeks of treatment. Wilcoxon's signed-rank test was used to compare median differences in VAS and PRI between perc-NMES and trans-NMES. RESULTS: Median VAS scores for perc-NMES and trans-NMES were 1 and 5.7, respectively (p = .007). Median PRI scores for perc-NMES and trans-NMES were 7 and 19.5, respectively (p = .018). Nine of the 10 subjects preferred perc-NMES to trans-NMES for treatment. CONCLUSION: Data suggest that perc-NMES is less painful than trans-NMES in the treatment of shoulder subluxation in hemiplegia.
Authors: Richard D Wilson; Maria E Bennett; Tina E Lechman; Kathryn W Stager; John Chae Journal: Arch Phys Med Rehabil Date: 2011-05 Impact factor: 3.966
Authors: Brian M Ilfeld; Christopher A Gilmore; Stuart A Grant; Michael P Bolognesi; Daniel J Del Gaizo; Amorn Wongsarnpigoon; Joseph W Boggs Journal: J Orthop Surg Res Date: 2017-01-13 Impact factor: 2.359
Authors: Brian M Ilfeld; Stuart A Grant; Christopher A Gilmore; John Chae; Richard D Wilson; Amorn Wongsarnpigoon; Joseph W Boggs Journal: Pain Pract Date: 2016-12-30 Impact factor: 3.183
Authors: Brian M Ilfeld; Rodney A Gabriel; Engy T Said; Amanda M Monahan; Jacklynn F Sztain; Wendy B Abramson; Bahareh Khatibi; John J Finneran; Pia T Jaeger; Alexandra K Schwartz; Sonya S Ahmed Journal: Reg Anesth Pain Med Date: 2018-08 Impact factor: 6.288
Authors: Brian M Ilfeld; Engy T Said; John J Finneran; Jacklynn F Sztain; Wendy B Abramson; Rodney A Gabriel; Bahareh Khatibi; Matthew W Swisher; Pia Jaeger; Dana C Covey; Catherine M Robertson Journal: Neuromodulation Date: 2018-08-30
Authors: Travis Cleland; Nitin B Jain; John Chae; Kristine M Hansen; Terri Z Hisel; Douglas D Gunzler; Victoria C Whitehair; Chong H Kim; Richard D Wilson Journal: Trials Date: 2020-03-06 Impact factor: 2.279